ClinicalTrialsFinder

Japanese Encephalitis Clinical Trials in Christchurch, Central City

1 recruitingChristchurch, Central City, New Zealand

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults

Japanese Encephalitis Virus Disease
SK Bioscience Co., Ltd.402 enrolled3 locationsNCT06680128